Intellia Therapeutics Inc (NTLA) returns
Intellia Therapeutics returns over 10 years
$1,000 invested in Intellia Therapeutics ten years ago was worth $962.19 at the close on October 30, 2026, with dividends reinvested: an average return of -0.4% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +3.4% | — | $1,034 | -0.9% |
| 3 months | +12.4% | — | $1,124 | +2.1% |
| Year to date | +38.7% | — | $1,387 | +11.7% |
| 1 year | +1.7% | — | $1,017 | +12.4% |
| 3 years | -47.7% | -19.4% | $523.29 | +88.5% |
| 5 years | -90.6% | -37.7% | $93.77 | +76.0% |
| 10 years | -3.8% | -0.4% | $962.19 | +316.6% |
Intellia Therapeutics return by calendar year
| Year | NTLA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +38.7% | +11.7% | +27.0% |
| 2025 | -22.9% | +17.7% | -40.6% |
| 2024 | -61.8% | +24.9% | -86.6% |
| 2023 | -12.6% | +26.2% | -38.8% |
| 2022 | -70.5% | -18.2% | -52.3% |
| 2021 | +117.4% | +28.7% | +88.6% |
| 2020 | +270.8% | +18.4% | +252.5% |
| 2019 | +7.5% | +31.2% | -23.7% |
| 2018 | -29.0% | -4.6% | -24.4% |
| 2017 | +46.6% | +21.7% | +24.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: NTLA financials
No forecast, no recommendation. This page describes Intellia Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.